CIMCX
Price
$27.40
Change
+$0.08 (+0.29%)
Updated
Jun 2 closing price
Net Assets
146.54B
LGMAX
Price
$27.03
Change
+$0.04 (+0.15%)
Updated
Jun 2 closing price
Net Assets
2.83B
Interact to see
Advertisement

CIMCX vs LGMAX

Header iconCIMCX vs LGMAX Comparison
Open Charts CIMCX vs LGMAXBanner chart's image
CIMCX vs LGMAX Comparison Chart in %
View a ticker or compare two or three
VS
CIMCX vs. LGMAX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMCX is a Buy and LGMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMCX has more cash in the bank: 147B vs. LGMAX (2.83B). CIMCX pays higher dividends than LGMAX: CIMCX (2.73) vs LGMAX (0.96). CIMCX was incepted earlier than LGMAX: CIMCX (24 years) vs LGMAX (20 years). CIMCX (1.35) is less costly to investors than LGMAX (1.16). CIMCX is a more actively managed with annual turnover of: 65.00 vs. LGMAX (35.00). CIMCX has a lower initial minimum investment than LGMAX: CIMCX (250) vs LGMAX (2500). LGMAX annual gain was more profitable for investors over the last year : 10.26 vs. CIMCX (8.06). CIMCX return over 5 years is better than : 20.12 vs. LGMAX (-2.30).
CIMCXLGMAXCIMCX / LGMAX
Total Expense Ratio1.351.16116%
Annual Report Gross Expense Ratio1.351.16116%
Fund Existence24 years20 years-
Gain YTD5.6546.51187%
Front LoadN/A6%-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets147B2.83B5,193%
Annual Yield % from dividends2.730.96284%
Returns for 1 year8.0610.2679%
Returns for 3 years33.0727.60120%
Returns for 5 years20.12-2.30-874%
Returns for 10 years67.7051.92130%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLCAX23.77N/A
N/A
JPMorgan US Large Cap Core Plus A
OINCX25.45N/A
N/A
JPMorgan Equity Income C
PHSKX37.47N/A
N/A
Virtus KAR Mid-Cap Growth A
MXNSX22.96N/A
N/A
Empower S&P SmallCap 600® Index L
RYCFX45.37N/A
N/A
Rydex Biotechnology C